Bpifrance Investissement, acting in its capacity as management company of the FPCI Innobio, has declared to the AMF that on August 23 it had individually fallen below the thresholds of 5% of Poxel's capital and voting rights.

As a result of this threshold crossing, which is the result of a sale of Poxel shares on the market, the declaring party specifies that it individually holds 1,720,181 shares, representing 4.90% of the capital and voting rights.720,181 shares representing 4.90% of the capital and voting rights.

EPIC Bpifrance has not crossed any thresholds and indirectly holds 4,308,272 Poxel shares, representing 12.26% of the capital and voting rights of this biopharmaceutical company.

Copyright (c) 2023 CercleFinance.com. All rights reserved.